Charged Alpha Stock Encyclopedia

Lamb Weston Holdings (LW) Q4 FY2026 — Lamb Weston (LW), the world's #1/#2 maker of frozen french fries, reported a strong fiscal Q4 2026: adjusted EPS of $0.87 beat the ~$0.63 estimate on net sales of $1.77B (+6% YoY, volume +7% — the 6th straight quarter of volume growth). But the beat was softer inside: adjusted EBITDA slipped 2% to $288M, GAAP EPS fell 7% to $0.79, and company-wide price/mix dropped 3% as the overbuilt fry industry pressures pricing. North America (~$1.21B, +9%) carried a shrinking International segment (~$564M, -2%). Full-year FY26 net sales of $6.61B and adjusted EBITDA of $1.147B both topped the high end of guidance. FY27 guide: flat-to-+1% sales, adj EBITDA $1.1-1.2B, adj EPS $2.95-3.25, driven by the activist-led 'Focus to Win' cost program ($250M+/yr). Free cash flow was $533M (flattered by slashed capex), and the dividend rose to $0.38/qtr (~3.1% yield). At ~$49.58, our owner-earnings DCF lands fair value near $50 — right at the price. Our call: HOLD, 3/5. We ALIGN with the Street (Hold, ~$50 target).

Lamb Weston (LW) is a bet on the global french fry — the #1 or #2 maker of frozen potato products on earth, the fries behind the drive-thru. Fiscal Q4 2026 was a headline beat: adjusted EPS of $0.87 crushed the ~$0.63 estimate on net sales of $1.77B (+6% YoY), with volume up 7% — a sixth straight quarter of volume growth. But look under the hood and it's softer: adjusted EBITDA slipped 2% to $288M, reported net income fell 9%, GAAP EPS dropped 7% to $0.79, and company-wide price/mix fell 3% — Lamb Weston sold more fries for less money as an overbuilt industry pressures pricing. It's a two-speed company: North America (~$1.21B, +9%, volume +11%) is winning share and carrying a struggling International segment (~$564M, -2%, price/mix -4% on Europe/Middle East weakness). Full-year FY26 net sales of $6.61B and adjusted EBITDA of $1.147B both beat the high end of guidance. The bull engine is self-help: activist JANA Partners won board seats, forced out the prior CEO, and launched 'Focus to Win,' targeting $250M+/yr in cost savings — but FY27 guides to ZERO revenue growth, so the EPS improvement ($2.95-3.25) is cost cuts and buybacks, not the top line. Free cash flow of $533M was flattered by slashed capex (FY27 implies closer to ~$400M), and the dividend rose to $0.38/qtr (~3.1% yield). The catch: at ~$49.58, our owner-earnings DCF — giving fair credit to the cost program — lands fair value right around $50. You're paying a fair price, which means the market already credits the turnaround. With negative price/mix, ~3.3x net leverage ($3.85B net debt), and no guided growth, there's no margin of safety. Our call: HOLD, 3/5 — and for once we ALIGN with the Street (Hold, ~$50 avg target). Own it for the yield and the activist optionality; add on real weakness toward the low $40s. Not financial advice.

THE CALL: HOLD (3/5, FAIRLY PRICED, TURNAROUND UNPROVEN — A REAL RECOVERY WITH NO MARGIN OF SAFETY) — base-case value ~$50 vs ~$49.58 today.

What to watch: durable proof the self-help is working — price/mix turning positive, International stabilizing or getting sold, and net leverage falling below 3x — which would justify a higher multiple and an upgrade; the risk to respect is price/mix getting worse as the overbuilt fry industry keeps discounting to fill capacity, or Europe/Middle East deteriorating further, which in a levered commodity staple could re-rate the stock toward the low $40s

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

RingCentral (RNG) Q2 2026 — RingCentral (RNG), the cloud-communications pioneer pivoting to AI-powered customer engagement, reported a clean Q2 2026 beat above the high end of its own guidance: non-GAAP EPS of $1.22 beat the ~$1.16 estimate (+15% YoY) on revenue of $657M (+5.9%), with subscriptions revenue of $634M (96% of total). Non-GAAP operating margin expanded to 23.4% and free cash flow jumped 25% to $180M (a 27% cash margin). Management RAISED full-year guidance across the board — total revenue to $2.635–2.646B, non-GAAP EPS to $4.96–$5.10, free cash flow to $615–625M — hiked the dividend 67% to $0.125/quarter, and refinanced ~$600M+ of convertible notes. The stock ripped ~25% to ~$48.31 (a new 52-week high, off a $23.59 low). Even after the pop it trades near ~10x forward earnings at a mid-teens FCF yield. Our owner-earnings DCF pegs fair value near $60 — even a melting-ice-cube case (~$53) tops the price. Our call: BUY, 4/5.

RingCentral (RNG) is a stock the market left for dead — a deeply profitable, cash-gushing cloud-communications company priced for slow death. Q2 2026 challenged that thesis hard: non-GAAP EPS of $1.22 beat the ~$1.16 estimate (+15% YoY) on revenue of $657M (+5.9%), subscriptions revenue of $634M (96% of total, ~6% growth), non-GAAP operating margin up 90bps to 23.4%, and free cash flow up 25% to $180M (a 27% cash margin). Management RAISED full-year guidance on revenue, margins, and cash (total revenue $2.635–2.646B, non-GAAP EPS $4.96–$5.10, FCF $615–625M), hiked the dividend 67%, refinanced $600M+ of convertible notes, and bought back $94M of stock — and the shares ripped ~25% to ~$48.31, a new 52-week high off a $23.59 low. The bull case: a 96%-recurring cash machine at ~10x earnings and a mid-teens free-cash-flow yield, shrinking its share count, deleveraging, and getting its AI/RingCX contact-center optionality (13% of ARR now AI-attached, doubled YoY) essentially for free. The bear case: ~6% growth in Microsoft Teams' crosshairs, ~$1.1B of debt and negative book equity, and ~$240M/yr of stock comp — a possible value trap. Our owner-earnings DCF is the tell: even a melting-ice-cube path (FCF declining ~3%/yr forever) is worth ~$53 at our base discount rate — above today's price — and an AI-reacceleration path is worth $90–$130+. We anchor conservatively near $60, ~24% above the price. Even after a 25% pop, the market is still pricing RingCentral for a slow death the numbers don't support — and notably, after the run the Street's average target near $43 now sits BELOW the price. Our call: BUY, 4/5. The risks are real, which is why it's a 4 and not a 5, but at ~10x earnings the odds favor the buyer. Own it, add on weakness into the low $40s, and watch the AI mix. Not financial advice.

THE CALL: BUY (4/5, A CASH MACHINE THE MARKET LEFT FOR DEAD — CHEAP EVEN AFTER A 25% POP) — base-case value ~$60 vs ~$48.31 today.

What to watch: hard evidence the AI mix-shift is re-accelerating growth — paid-AI ARR climbing past 13%, RingCX winning larger contact-center deals, and total revenue growth pushing back toward double digits — which would flip the story from value to growth-and-value and justify a rerating; the risk to respect is Microsoft Teams taking net UCaaS seats, net retention slipping, and revenue rolling into decline, which on a levered balance sheet (~$1.1B debt, negative book equity) would turn a cheap stock into a value trap

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

American Airlines Group (AAL) Q2 2026 — American Airlines (AAL), the largest U.S. airline by fleet, reported a Q2 2026 that beat the quarter but cut the year: RECORD revenue of $16.74B (+16.3% YoY) and adjusted EPS of $0.15 beat the ~$0.03 estimate — but that EPS was down from ~$0.95 a year earlier as a fuel bill up 83% YoY to $4.88B crushed the operating margin to just 2.7%. The stock fell ~8% on the print (before bouncing to ~$14.48) because management CUT full-year 2026 adjusted-EPS guidance to a range of a $0.65 loss to a $0.65 profit (breakeven midpoint), down from -$0.40 to +$1.10 in April, citing ~$1.6B of added H2 fuel cost. Bright spots were real: premium revenue +19%, managed corporate revenue +26%, AAdvantage loyalty enrollments +32% (record). But American is the most leveraged legacy carrier: ~$34.7B net debt (~10x EBITDA), NEGATIVE book equity (-$4.0B), ~$7.8B liquidity, ~$1.9B TTM free cash flow going to deleveraging. Valuing normalized earnings power (~$1.50-$2.50/share) on a leveraged-carrier P/E of 6-8x, our probability-weighted fair value is ~$12 vs ~$14.48 today — with an EV/EBITDA cross-check showing the equity is a thin sliver on a $34.7B debt stack. Our call: HOLD, 2/5 — cautious. We're below the Street's ~$18 average target (Hold; +24%). Own it only cheaper, into the low teens, and respect the leverage. Not financial advice.

American Airlines (AAL) is the largest U.S. airline by fleet — a global network built on hubs in Dallas-Fort Worth, Charlotte and Miami, with a genuinely great loyalty engine in AAdvantage. Q2 2026 was a beat-the-quarter, cut-the-year story: RECORD revenue of $16.74B (+16.3% YoY) and adjusted EPS $0.15 beat the ~$0.03 estimate — but EPS fell from ~$0.95 a year ago as fuel jumped 83% YoY to $4.88B and squeezed the operating margin to 2.7%. The stock dropped ~8% on the print because management CUT full-year 2026 guidance to a $0.65 loss-to-$0.65 profit range (breakeven), down from -$0.40 to +$1.10, on ~$1.6B of added second-half fuel cost. The bull case is real: premium revenue +19%, corporate +26%, loyalty enrollments +32% (record) — a margin-lifting mix shift. But American is the most leveraged of the big three: ~$34.7B net debt (~10x EBITDA), negative book equity, ~$7.8B liquidity, ~$1.9B TTM free cash flow funding debt paydown. Because the equity is a thin sliver on a huge debt stack, we value normalized earnings power (~$1.50-$2.50/share) at a leveraged-carrier 6-8x P/E: our probability-weighted fair value is ~$12 vs ~$14.48, with an EV/EBITDA cross-check underscoring how fragile the equity is. Our call: HOLD, 2/5 — cautious. We sit below the Street's ~$18 average target ($13-$25 range; Hold, +24%). Own it only cheaper, into the low teens, and respect the leverage. Not financial advice.

THE CALL: HOLD (2/5, RECORD REVENUE, BUT LEVERAGE CAPS THE EQUITY — A WELL-RUN AIRLINE PRICED A LITTLE ABOVE A FAIR VALUE, ON THE MOST LEVERAGED BALANCE SHEET IN THE GROUP) — base-case value ~$12.00 vs ~$14.48 today.

KEY METRICS:

- RECORD revenue $16.74B, +16.3% YoY; adjusted EPS $0.15 beat the ~$0.03 estimate but fell from ~$0.95 a year earlier

- Fuel cost +83% YoY to $4.88B, compressing the adjusted operating margin to just 2.7%

- FY2026 adjusted-EPS guidance CUT to a range of a $0.65 loss to a $0.65 profit (breakeven midpoint), down from -$0.40 to +$1.10 in April; ~$1.6B of added H2 fuel cost

- Bright spots: premium revenue +19% YoY, managed corporate revenue +26%, AAdvantage loyalty enrollments +32% (a record)

- Most leveraged legacy carrier: ~$34.7B net debt (~10x EBITDA), NEGATIVE book equity (-$4.0B), ~$7.8B liquidity (cash + short-term investments)

- ~$1.9B TTM free cash flow funding deleveraging; ~663M diluted shares; ~$9.6B market cap, ~$44B enterprise value

- Valuation on normalized earnings power (~$1.50-$2.50/share) at a leveraged-carrier 6-8x P/E; EV/EBITDA cross-check ~5.5x on ~$6B normalized EBITDA shows a thin equity on a $34.7B debt stack

- Our probability-weighted fair value ~$12 vs ~$14.48 price (~17% downside); Street ~$18 avg target ($13-$25 range), Hold, +24% — our call HOLD, 2/5, cautious (we differ)

What to watch: hard evidence the fuel headwind is fading, continued strength in premium and corporate revenue, and above all net debt grinding below $30B (deleveraging is the biggest lever on this thin equity) — which would justify paying up and prompt an upgrade; the risks to respect are a sustained fuel spike or a demand slump into recession, either of which hits the most leveraged legacy carrier hardest, plus the negative book equity that leaves almost no cushion

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Mobileye Global (MBLY) Q2 2026 — Mobileye (MBLY), the dominant supplier of automotive vision (ADAS) chips, reported a Q2 2026 double beat: adjusted EPS of $0.19 crushed the ~$0.06 estimate and revenue of $508M beat ~$482M, with adjusted operating income +46% YoY to $155M (31% margin). But the stock FELL ~15%. Why? Revenue was flat YoY, GAAP was a small loss (~$0.03), and a one-time $93M Israeli R&D tax credit MORE than accounted for the entire operating-profit increase — core margin was ~12%, not 31%. Add a CEO transition (founder Amnon Shashua stepping aside to chairman), Intel's ~88% ownership overhang, ~$340M/yr of stock-based comp that nearly offsets the ~$390M TTM free cash flow, and a new, capital-intensive pivot to build its own robotaxi fleet (2027 launch). MBLY raised FY26 revenue guidance to ~$1.995B (+4-7%) and adj. operating income to $395M (includes the credit). With ~$1.44B net cash (~$1.76/share, zero debt) the balance sheet is a fortress, but real owner-earnings are near breakeven. On a reverse-DCF, the ~$5.1B enterprise value (~2.6x flat sales) prices in a wide range; our probability-weighted fair value is ~$8.50 vs ~$8.05 today. Our call: HOLD, 3/5 — a real beat, but flat and flattered. We're more cautious than the Street's ~$10.45 target (+30%).

Mobileye (MBLY) is the eyes of the modern car — its EyeQ chips power the automatic braking and lane-keeping in ~200M vehicles, an estimated ~70% share of the driver-assist (ADAS) market across ~50 automakers (Intel still owns ~88%). Q2 2026 looked like a clean double beat: adjusted EPS $0.19 vs ~$0.06, revenue $508M beat ~$482M, adjusted operating income +46% to $155M at a 31% margin. Yet the stock DROPPED ~15%. The reason is in the fine print: revenue was flat YoY, GAAP was still a ~$0.03 loss, and a one-time $93M Israeli R&D tax credit MORE than accounted for the entire profit increase — strip it out and the core margin was ~12% and underlying profit went backwards. On top of that: founder-CEO Amnon Shashua is stepping aside to become chairman, Intel is an ~88% seller-in-waiting, ~$340M/yr of stock comp nearly offsets the ~$390M TTM free cash flow (real owner-earnings ~breakeven), and Mobileye just reversed course to build and operate its OWN robotaxi fleet (2027 U.S. launch) — a big, capital-intensive bet. Management raised FY26 guidance (revenue midpoint ~$1.995B, +4-7%; adj. operating income $395M, which still banks the credit), and volumes were solid at 10M EyeQ units (+3%). The balance sheet is a fortress: ~$1.44B net cash, ~$1.76/share, zero debt. But with real owner-earnings near breakeven, we value it on a path-to-profitability + reverse-DCF frame: the ~$5.1B enterprise value (~2.6x flat sales) prices in a wide outcome range, and our probability-weighted fair value lands near $8.50 vs ~$8.05 today. Our call: HOLD, 3/5 — a good franchise near a 52-week low with real optionality, but flat, flattered, and about to spend big on robotaxis. We're more cautious than the Street (~$10.45 avg target, +30%). Own it small for the optionality and add toward the mid-$6s. Not financial advice.

THE CALL: HOLD (3/5, A REAL BEAT, BUT FLAT REVENUE AND A FLATTERED PROFIT — A GOOD FRANCHISE NEAR ITS LOW, PRICED ABOUT FAIR) — base-case value ~$8.50 vs ~$8.05 today.

KEY METRICS:

- Adjusted EPS $0.19, beat ~$0.06 estimate; GAAP a small loss (~$0.03) on heavy amortization

- Revenue $508M, roughly FLAT YoY, beat ~$482M consensus; EyeQ volume 10M units (+3%)

- Adjusted operating income $155M (+46% YoY), 31% margin (+~10 pts) — but a one-time $93M Israeli R&D credit MORE than accounted for the entire increase; core margin ~12%

- FY2026 guidance RAISED: revenue midpoint ~$1.995B (+4-7%), adj. operating income $395M (includes the credit)

- Founder-CEO Amnon Shashua stepping aside to become chairman; Mobileye pivoting to build/operate its OWN robotaxi fleet (2027 U.S. launch)

- Net cash ~$1.44B (~$1.76/share), zero debt; TTM free cash flow ~$390M but ~$340M/yr stock comp nearly offsets it (real owner-earnings ~breakeven)

- Intel still owns ~88% of MBLY — a large share overhang; ~818M diluted shares

- Reverse-DCF: ~$5.1B enterprise value (~2.6x flat sales); our prob-weighted fair value ~$8.50 vs ~$8.05 price; Street ~$10.45 avg target (Buy, +30%) — our call HOLD, 3/5

What to watch: hard evidence the growth products are reaccelerating — SuperVision winning Western automakers, Chauffeur design wins piling up, and revenue reaccelerating into double digits on its own merits rather than on the one-time tax credit — which would justify paying up and prompt an upgrade; the risks to respect are the robotaxi build burning cash with no clear payoff, Intel dumping its ~88% stake into the market, or ADAS staying flat while the R&D credit fades

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Kinder Morgan (KMI) Q2 2026 — Kinder Morgan (KMI), the toll road on America's natural gas, reported a record Q2 2026: adjusted EPS of $0.37 beat the ~$0.32 estimate (+32% YoY) on revenue of $4.48B (+11% YoY), record adjusted EBITDA of $2.2B (+12%), and record Q2 net income of $867M (+21%). Management RAISED its full-year outlook (now >12% above budget on adjusted EPS) and declared a $0.2975 quarterly dividend ($1.19 annualized, +2% YoY, ~3.6% yield), backed by a $9.6B project backlog that is 92% natural gas. The stock (~$32.86) has run ~28% off its $25.60 low to within ~6% of its $34.81 high. Even respecting the leverage (~3.6x net debt/EBITDA) and long-run transition risk, our owner-earnings DCF lands fair value near $36 — modestly above the price. Our call: HOLD, 3/5 — a high-quality income compounder, now fairly priced.

Kinder Morgan is the toll road on America's natural gas — a ~$73B energy-infrastructure company that owns ~78,000 miles of pipeline and moves roughly 40% of the gas the U.S. burns or exports. Q2 2026 was a record: adjusted EPS of $0.37 beat ~$0.32 (+32% YoY), revenue rose ~11% to $4.48B, adjusted EBITDA hit a Q2 record $2.2B (+12%), and net income of $867M was an all-time Q2 high (+21%). The engine was natural gas — transport volumes +7% on LNG exports and data-center power demand, gathering volumes +26% — and management RAISED full-year guidance (now >5% above budget on EBITDA, >12% on EPS). The dividend rose 2% to $0.2975/quarter ($1.19/yr, ~3.6% yield), covered ~2x by distributable cash flow, and a $9.6B backlog (92% natural gas, 60%+ tied to power generation and utilities) can be self-funded from internal cash. So the debate isn't quality — it's price. After a ~28% run to ~$32.86, KMI trades ~11.5x EBITDA and ~21x earnings. Respecting ~$32B of net debt (~3.6x EBITDA) and the long-run energy-transition question, our owner-earnings DCF (steady +3% vs data-center +6% paths, discounted 8-10%) lands fair value near $36 — only modestly above the price. A wonderful, boring cash machine, now fairly valued. Our call: HOLD, 3/5 — we're basically aligned with the Street's ~$35 target. Own it for the well-covered, growing yield and the LNG/data-center demand tailwind; add on real weakness in the high $20s. Not financial advice.

THE CALL: HOLD (3/5, A HIGH-QUALITY TOLL ROAD, NOW FAIRLY PRICED — A RECORD BEAT-AND-RAISE WITH A THIN MARGIN OF SAFETY) — base-case value ~$36 vs ~$33 today.

KEY METRICS:

- Adjusted EPS $0.37, beat ~$0.32 estimate (+32% YoY); GAAP EPS $0.39 (+22%)

- Revenue $4.48B (+11% YoY); record adjusted EBITDA $2.2B (+12%)

- Net income attributable to KMI $867M — record Q2 (+21% YoY)

- Dividend $0.2975/qtr ($1.19/yr, +2%, ~3.6% yield), covered ~2x by distributable cash flow

- Project backlog $9.6B (92% natural gas, 60%+ power gen + utilities), ~5.5x first-year EBITDA, self-funded

- Net debt ~$32B (~3.6x EBITDA, low end of target); raised FY26 outlook (>12% above budget on adj EPS)

- Gas transport volumes +7%, gathering +26%; moves ~40% of U.S. natural gas across ~78,000 miles of pipe

- Our owner-earnings DCF fair value ~$36 vs ~$33 price; Street ~$35 target — HOLD, 3/5

What to watch: hard evidence the natural-gas demand wave is accelerating — the backlog growing, more data-center and LNG transport contracts signed, and adjusted EBITDA compounding at the high end of our range — which would justify a higher multiple and prompt an upgrade; the risks to respect are a stall in gas demand, a spike in interest rates that pressures a ~$32B (leveraged) balance sheet, or a policy shift against fossil-fuel infrastructure

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Grupo Aeroportuario del Sureste (ASUR) (ASR) Q2 2026 — Grupo Aeroportuario del Sureste (ASUR, NYSE ADR 'ASR'), the Mexican monopoly that runs Cancún plus airports in Colombia and Puerto Rico, reported Q2 2026 with headline revenue up 9.9% to Ps.9.6B — but that's a mirage: strip out IFRIC-12 construction revenue (which nearly doubled) and revenue was flat (-0.3%) while EBITDA actually fell 8.7% and passenger traffic dropped 2.7% on Cancún softness. Majority net income still rose 7.1% (~$4.38/ADR). The ADR has fallen ~30% to a 52-week low near $268. Our call: BUY, 3/5.

How does an airport report 10% revenue growth and still crater to a 52-week low? ASUR is a toll road for the sky — 50-year monopoly concessions over Cancún and eight more southeast-Mexico airports (to 2048), plus six in Colombia and San Juan, Puerto Rico. In Q2 2026 the reported 9.9% revenue jump was an accounting mirage: IFRIC-12 construction revenue nearly doubled with an exactly offsetting cost, so strip it out and revenue was flat, EBITDA fell 8.7%, and the reported margin sank from 58% to 48% (still a fat 62% ex-construction). The market's real fear is traffic: total passengers -2.7%, Mexico -5% as Cancún lost ~500k flyers to a fuel spike, Spirit Airlines' bankruptcy, record Sargassum, and a no-show World Cup bump — the CEO admitted 'the summer is lost' but expects a better winter. Underneath, Colombia grew 3.6%, the MDP tariff cycle keeps ratcheting inflation-linked pricing (new Cancún Terminal 1 opens Q4 2026), the balance sheet is still low at 0.9x net debt, and a potential ~Ps.30/share (~6%) dividend pays you to wait. The catch: a deteriorating passenger mix risks under-recovering the regulated tariff, leverage has risen from ~0x, and management is busy with M&A (a US commercial arm, a big pending Motiva deal). Our owner-earnings DCF, leaning toward recovery at a quality 9% discount, lands fair value near $315 vs ~$268 today — ~18% upside plus the dividend. Our call: BUY, 3/5 — a de-rated monopoly at a cyclical air-pocket; accumulate on weakness. We're constructive but more conservative than the Street's ~$376 Buy. Not financial advice.

THE CALL: BUY (3/5, A DE-RATED MONOPOLY AT A CYCLICAL AIR-POCKET — CHEAP QUALITY AT A 52-WEEK LOW) — base-case value ~$315 vs ~$268 today.

What to watch: confirmation the traffic air-pocket was temporary — winter passenger data recovering, Cancún stabilizing, the MDP tariff step-ups landing with the new Terminal 1, and the two special dividends passing the August vote; the risk to respect is the softness dragging into 2027, a persistently strong peso deflating dollar revenue, or the regulated tariff formally under-recovering as the higher-value US/international passenger mix erodes

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

LG Display (LPL) Q2 2026 — LG Display (LPL), the Korean maker of the OLED panels inside your TV and a huge share of the world's iPhones, reported Q2 2026: revenue of KRW 5.61 trillion (~$3.8B, +1% QoQ), an operating loss of KRW 108B (~-$73M) and a net loss of KRW 419B (~-$283M) — but the loss was driven by a one-off voluntary-retirement charge, and the first HALF of 2026 was profitable, its first H1 profit in 5 years. OLED is now 57% of revenue. The stock fell ~6% to a 52-week low near $3.17. The catch: ~$8.7B of net debt vs a $3.2B market cap, and free cash flow is still negative. It trades at ~0.7x book. Our call: HOLD, 3/5 — a leveraged OLED turnaround, cheap but unproven; fair value ~$3.75.

LG Display is a genuine contradiction. For years it was a commodity LCD maker getting crushed by Chinese price wars — three straight years of losses and a balance sheet buried under debt. Now it's pivoted hard to premium OLED (57% of revenue, up from ~40%) and is one of only two companies on earth (with Samsung Display) qualified to supply the OLED panels in Apple's iPhones. Q2 2026 was messy on the surface — revenue KRW 5.61T (~$3.8B), an operating loss of KRW 108B and a net loss of KRW 419B (~-$283M) — but that loss came almost entirely from a one-off voluntary-retirement charge; ex-charge it would have been operating-profitable, and the first HALF of 2026 was profitable, LG Display's first H1 profit in five years (since 2021). Area shipments rose 12% QoQ and management guided Q3 shipments up mid-single-digits. Yet the stock fell ~6% on the print to a 52-week low near $3.17, trading at just ~0.7x book value. The overhang is the balance sheet: ~$8.7B of net debt against a $3.2B market cap (net debt ~2.7x equity) and still-negative free cash flow. That leverage means the equity is a geared bet on deleveraging — do OLED profits outgrow the interest bill, or not? Our fair value lands near $3.75 (base ~0.8x book; bear ~$2.55, bull ~$5.05), modestly above the price. Our call: HOLD, 3/5 — a real OLED turnaround at a deep discount to book, wrapped around one of the scariest balance sheets in tech. We line up with the Street (also Hold, ~$4.24 avg target on thin ADR coverage), just a shade more cautious. Size it small, demand proof the debt is falling. Not financial advice.

THE CALL: HOLD (3/5, A LEVERAGED OLED TURNAROUND — CHEAP, BUT UNPROVEN) — base-case value ~$3.75 vs ~$3.17 today.

What to watch: hard evidence of deleveraging — net debt falling quarter over quarter, free cash flow turning positive, and OLED margins expanding through the Apple iPhone ramp — which would re-rate the stock from ~0.7x book toward 1x and prompt an upgrade; the risk to respect is free cash flow staying negative while the debt compounds, a price war spreading into OLED, or Apple diversifying its OLED supplier base, any of which would let the ~$8.7B net-debt load overwhelm the recovery

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

SS&C Technologies Holdings, Inc. (SSNC) Q2 2026 — SS&C Technologies (SSNC), the software plumbing behind the asset-management industry, reported RECORD Q2 2026 results and the stock jumped ~10%. Adjusted EPS of $1.76 beat the ~$1.68 estimate (+18% YoY) on revenue of $1,695.7M (+10.3%), and adjusted EBITDA hit a record $670.7M at a 39.5% margin. The star was adjusted ORGANIC revenue growth of 7.6% - a multi-year high for a company the Street had written off as a low-single-digit roll-up. Technology-enabled services (fund admin, outsourced ops, Blue Prism automation) rose 11.1% to $1,408.2M (83% of revenue); license/maintenance was $287.5M (+6.8%). But mind the gap: GAAP EPS was just $0.97 (+34.7%) - about half the adjusted figure, most of the difference amortization of acquired intangibles. The balance sheet carries the roll-up's legacy: $7,613.5M gross debt, 2.75x net leverage, ~$410M/yr interest. Cash generation is strong: 1H26 operating cash flow $716.4M (+11.1%), FCF ~$1.45B (~8% yield). Capital allocation is the tell - SS&C returned $499.2M to shareholders in Q2 (a record 6.4M-share, $435.2M buyback + $64.0M dividends) and 100% of allocated capital YTD, a founder-led company buying its own stock rather than paying down debt. It raised FY26 guidance to adj revenue $6,672-6,832M and adj EPS $6.93-7.25 (~+18%). At ~$74 the stock is ~19% below its $91 high and trades ~12x FCF. Our owner-earnings DCF (10% discount to respect the leverage) lands fair value near $92 (~25% upside). Our call: BUY, 4/5.

SS&C Technologies is the unglamorous software plumbing behind the money-management industry - the back-office systems and outsourced operations that thousands of hedge funds, private-equity firms, insurers and wealth managers run on. Founded in 1986 and still run by founder Bill Stone, it serves 23,000+ clients with ~97% recurring revenue. Q2 2026 was a record: adjusted EPS of $1.76 beat ~$1.68 (+18% YoY) on revenue of $1,695.7M (+10.3%), with a record 39.5% adjusted EBITDA margin - and the stock popped ~10%. The star was adjusted organic revenue growth of 7.6%, a multi-year high for a company long dismissed as a slow, debt-heavy roll-up; technology-enabled services rose 11% to 83% of revenue. But the tension is real: GAAP EPS was just $0.97, barely half the adjusted number (most of the gap is amortization of acquired intangibles), the balance sheet carries $7.6B of debt at 2.75x leverage and ~$410M/yr interest, and growth still leans on M&A. The tell is capital allocation: SS&C returned $499M to shareholders in Q2 (a record 6.4M-share buyback) and 100% of allocated capital YTD - a founder buying his own stock rather than cutting debt. It raised FY26 guidance to adj EPS $6.93-7.25 (~+18%). At ~$74 the stock sits ~19% below its $91 high, ~12x free cash flow, an ~8% FCF yield. Our owner-earnings DCF - deliberately using a higher 10% discount rate for the leverage and conservative growth - lands fair value near $92, about 25% above the price. Our call: BUY, 4/5 - cheap on cash flow, if you trust the roll-up. We're aligned with the Street's Buy (avg target ~$92) but got there by valuing the cash flows ourselves. Accumulate here, add on weakness toward the low $60s. Not financial advice.

THE CALL: BUY (4/5, CHEAP ON CASH FLOW, IF YOU TRUST THE ROLL-UP - A REACCELERATING, FOUNDER-LED CASH MACHINE AT ~12x FCF) — base-case value ~$92 vs ~$73.88 today.

What to watch: evidence the organic reacceleration is durable - adjusted organic revenue growth holding at 6%+ for several quarters, net leverage grinding below 2.5x, and the buyback continuing - which would force the market to re-rate SSNC as a compounder rather than a slow roll-up and support the move toward our ~$92 fair value; the risk to respect is that organic growth fades back toward the historical ~4-5%, a large debt-funded acquisition re-levers the balance sheet, or higher-for-longer rates keep the ~$410M annual interest bill heavy, leaving a leveraged business whose GAAP earnings are only a third of the adjusted figure

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Deckers Outdoor Corporation (DECK) Q1 FY2027 — Deckers Brands (DECK), the parent of HOKA and UGG, reported fiscal Q1 FY2027 (quarter ended June 30, 2026): revenue of $1.020B (+5.7% YoY; +4.8% constant-currency) — its first-ever billion-dollar first quarter — diluted EPS of $0.94 (beat the ~$0.87 estimate; +1% YoY), and gross margin of 56.4% (+60 bps). Management RAISED full-year FY2027 EPS guidance by 5 cents to $7.35-$7.50 and held revenue at $5.86-$5.91B. Yet the stock fell after the print and sits near its 52-week low (~$96 vs a ~$126 high). The honest read: this was a LOW-QUALITY beat. HOKA — the entire growth engine — grew just 7.7% to $703.5M (down from 30%+ two years ago), UGG grew 4.9% to $278.0M, and Other brands fell 18.1% to $37.9M (Koolaburra wind-down). Operating income actually FELL 6% ($155.3M vs $165.3M) as SG&A jumped 12.7% on marketing, stores and tariffs; EPS only rose because the share count shrank ~7.4% via buybacks. FY2027 op-margin guidance was cut to ~21.5% (from 22.8%), and the outlook explicitly assumes NO refunds on tariffs already paid. Bright spots: DTC +13.0% (comps +6.8%), international +8.4% (vs domestic +3.2%). Balance sheet is a fortress — $1.6B cash, zero debt (~12% of market cap), $338M repurchased in Q1 and $4.7B still authorized (~35% of the company). At ~13x TTM EPS with net cash, our owner-earnings DCF lands fair value ~$120 (base 9% discount, decelerator path) — ~25% above the ~$96 price; even the most cautious corner of the grid ($107) is above the price. Our call: BUY, 4/5 — the market over-punished a debt-free brand machine, but HOKA's growth rate is the one thing to watch.

Deckers Brands (NYSE: DECK) is the company behind two of the hottest names in footwear: HOKA, the maximalist performance-running brand, and UGG, the 60-year-old sheepskin-boot icon. Fiscal Q1 FY2027 (quarter ended June 30, 2026) looked like a clean beat-and-raise on the surface: revenue of $1.020B (+5.7%; +4.8% constant currency) crossed $1 billion in a first quarter for the first time ever, diluted EPS of $0.94 beat the ~$0.87 estimate, gross margin ticked up to 56.4%, and management raised full-year EPS guidance to $7.35-$7.50. And yet the stock fell and now trades near its 52-week low around $96, down ~24% from a ~$126 high, at just ~13x trailing earnings — a value multiple for a brand that compounded at 20%+ for years. Why? Because it was a low-quality beat. HOKA, the entire growth thesis, grew only 7.7% to $703.5M — a sharp deceleration from 30%+ two years ago as Nike re-emerges and On Running surges. UGG grew 4.9% to $278.0M. Operating income actually FELL 6% to $155.3M because SG&A jumped 12.7% (marketing, new stores, tariffs); EPS only rose a penny because Deckers retired ~7.4% of its shares. The full-year guide even cut operating-margin expectations to ~21.5% (from 22.8%) and assumes no collection of refunds on tariffs already paid — a real headwind on Asia-sourced footwear. The bright spots are genuine: DTC sales +13.0% with comps +6.8%, and international +8.4% versus a soft +3.2% at home. And the balance sheet is a fortress: $1.6B cash, zero debt (~12% of market cap), $338M bought back in Q1 at ~$104, and a staggering $4.7B still authorized (~35% of the company). So how do you value a decelerating brand compounder? We run an owner-earnings DCF on ~$1.0B of normalized free cash flow (net income guided ~$1.03B, high conversion) across two scenarios — a decelerator at +2.5%/yr and a compounder at +7%/yr — discounted at 8/9/10%. The base case (decelerator, 9%) lands ~$121 a share including net cash; even the harshest corner (decelerator, 10%) is ~$107, still above the price, and the compounder path runs to $150-$200+. We anchor fair value at ~$120, roughly 25% above the ~$96 stock. Wall Street rates DECK a Buy (26 buy / 24 hold / 6 sell, 56 analysts) with a ~$118 average target ($85-$145 range), though targets were cut after the print (BofA to $105, Stifel to $133) — a genuinely divided tape. Our call: BUY, 4/5 — a debt-free, 56%-gross-margin brand machine the market over-punished; add on weakness, and watch HOKA's growth rate every quarter, because that one number is the call. Not financial advice.

THE CALL: BUY (4/5, A DEBT-FREE, HIGH-MARGIN BRAND MACHINE (HOKA + UGG) THE MARKET OVER-PUNISHED — ~$120 FAIR VALUE VS ~$96, WITH HOKA'S GROWTH RATE THE ONE THING TO WATCH) — base-case value ~$120 vs ~$96 today.

KEY METRICS:

- Revenue $1.020B (+5.7% YoY; +4.8% constant currency) — first-ever $1B first quarter

- Diluted EPS $0.94 (beat ~$0.87; +1% YoY) — but net income FELL 6.6% to $130.0M; EPS up only via buybacks

- HOKA $703.5M (+7.7%, decelerating from 30%+); UGG $278.0M (+4.9%); Other $37.9M (-18.1%, Koolaburra wind-down)

- Operating income $155.3M (DOWN 6% YoY) as SG&A rose 12.7%; operating margin 15.2% vs 17.1%

- Channel: DTC $352.8M (+13.0%, comps +6.8%) vs Wholesale $666.7M (+2.2%); Intl $502.1M (+8.4%) vs Domestic $517.4M (+3.2%)

- Gross margin 56.4% (+60 bps YoY)

- FY2027 guide RAISED: EPS $7.35-$7.50 (+$0.05), revenue $5.86-$5.91B; op margin cut to ~21.5% (from 22.8%); assumes no tariff refunds

- Balance sheet: $1.603B cash, ZERO debt (~12% of market cap); inventory $807.6M

- Capital return: $338.2M repurchased in Q1 (3.3M shares @ ~$104); $4.7B remaining authorization (~35% of the company); buyback guided at ~80% of FY27 FCF

- Valuation: ~13x TTM EPS ($7.02), ~13x forward ($7.43 guide midpoint); our owner-earnings DCF fair value ~$120 vs ~$96 price

What to watch: HOKA re-accelerating toward its guided low-double-digit full-year pace (with DTC comps staying strong and international broadening) would re-rate the stock quickly off a ~13x multiple toward the $150+ compounder scenario and the Street's high-end $145 target; the buyback (~$4.7B authorized, ~80% of FCF) keeps compounding per-share value in the meantime. The risk to respect: HOKA decelerating FURTHER toward mid-single-digit growth like UGG, or tariffs/discounting cracking the 56% gross margin — that would make DECK a low-single-digit grower for which ~13x is fair, not cheap (a value trap). Because HOKA is the entire growth thesis, its year-over-year growth rate is the single number to watch every quarter.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Tenet Healthcare (THC) Q2 2026 — Tenet Healthcare (THC), the Dallas hospital + ambulatory-surgery operator, delivered a blowout Q2 2026 and RAISED full-year guidance — and the stock jumped ~17% to ~$233. Adjusted diluted EPS of $6.12 (+52% YoY vs $4.02) crushed the $4.26 estimate, on revenue of $5.63B (+6.8%) and adjusted EBITDA of $1.30B (+16%), with the adjusted EBITDA margin EXPANDING from 21.3% to 23.2%. The USPI ambulatory-surgery segment (the largest ASC operator in the U.S.) grew adjusted EBITDA 9% to $542M at a 39% margin, with same-facility revenue +5% and total-joint-replacement volumes +10%. Management raised FY2026 adjusted EPS guidance to $20.30–$21.69 (from ~$17.85), adjusted EBITDA to $4.83–$5.03B (+$295M midpoint), revenue to $21.9–$22.5B, and adjusted FCF ~$225M. Tenet has deleveraged to ~2.2x net debt/EBITDA (~$11B net debt), repurchased $1.04B of stock in Q2, and expanded its buyback authorization by $2.0B (~$2.13B remaining). The quarter was partly flattered by non-recurring prior-year Medicaid supplemental payments and contract-termination revenue, and an ACA-subsidy/payer-mix headwind looms into 2026-27. Our owner-earnings DCF + segment sum-of-parts lands fair value near $250 vs ~$233. Our call: BUY, 3/5 — the transformation is real, but much of the beat-and-raise is now priced in.

Tenet Healthcare (THC) is a ~$20B Dallas-based operator of ~50 acute-care hospitals, the Conifer revenue-cycle business, and — the crown jewel — USPI (United Surgical Partners), the largest ambulatory-surgery-center operator in America with ~500 centers, led by CEO Dr. Saum Sutaria. The story is a deliberate transformation: Tenet sold dozens of hospitals and reinvested the proceeds into high-margin surgery centers and debt paydown, morphing from a leveraged hospital chain into an ambulatory-surgery compounder. Q2 2026 was a blowout beat-and-raise: adjusted diluted EPS of $6.12 (+52% YoY) crushed the $4.26 estimate, revenue rose 6.8% to $5.63B, and adjusted EBITDA jumped 16% to $1.30B — with the margin EXPANDING from 21.3% to 23.2%. USPI grew adjusted EBITDA 9% to $542M at a 39% margin (same-facility revenue +5%, total-joint volumes +10%). Management RAISED full-year guidance across the board: adjusted EPS to $20.30–$21.69 (from ~$17.85), adjusted EBITDA to $4.83–$5.03B (+$295M at the midpoint), revenue to $21.9–$22.5B, and adjusted free cash flow by ~$225M. Deleveraging (to ~2.2x net debt/EBITDA, ~$11B net debt) has unlocked aggressive capital returns — $1.04B repurchased in Q2 and a $2.0B buyback-authorization expansion (~$2.13B remaining) on a share count down to ~84M. The honest catch: the quarter was partly flattered by non-recurring prior-year Medicaid supplemental payments and one-time contract-termination revenue, and an ACA enhanced-subsidy expiration / payer-mix cliff is a real headwind into 2026-27. The stock had already round-tripped ($148 low → $245 high → ~$179 in June) before exploding ~17% to ~$233 on the print, back near its 52-week high. Our owner-earnings DCF (9/10/11%) plus a USPI-vs-hospitals segment sum-of-parts lands fair value near $250 — modestly above the price — with the buyback adding a per-share tailwind. Our call: BUY, 3/5 — a deleveraged ambulatory compounder where the transformation is genuine, but much of the beat-and-raise is now priced in. Wall Street is a Buy (26 buy / 6 hold) with a ~$255 average target, though the freshest post-print targets (Wells Fargo $231, BofA $230, Barclays $240, Guggenheim $242) cluster right at today's price. Add on the pullbacks it keeps handing you, and watch USPI volumes and the payer mix. Not financial advice.

THE CALL: BUY (3/5, A DELEVERAGED AMBULATORY COMPOUNDER — A BEAT-AND-RAISE, WITH MUCH NOW PRICED IN) — base-case value ~$250 vs ~$233 today.

What to watch: evidence the USPI ambulatory-surgery flywheel keeps outrunning the payer-mix drag — USPI becoming an ever-larger share of EBITDA at ~39% margins, continued deleveraging, and the buyback rolling on — which would justify an upgrade toward 4/5; the risk to respect is the ACA enhanced-subsidy expiration / payer-mix and Medicaid-supplemental headwind biting harder than guided into 2026-27, or the one-time items (prior-year Medicaid supplemental payments, contract-termination revenue) proving to have masked a weaker underlying trend near a 52-week-high price

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.